CYP2C9 c.1426T>C ;(p.F476L)

Variant ID: 10-96748738-T-C

NM_000771.3(CYP2C9):c.1426T>C;(p.F476L)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19.

Pharmacotherapy
Jorgensen, Sarah C J SCJ; Kebriaei, Razieh R; Dresser, Linda D LD
Publication Date: 2020-07

Variant appearance in text: CYP2C9: F476L
PubMed Link: 32446287
Variant Present in the following documents:
  • PHAR-9999-na.pdf
View BVdb publication page



CYP2C9 amino acid residues influencing phenytoin turnover and metabolite regio- and stereochemistry.

The Journal Of Pharmacology And Experimental Therapeutics
Mosher, Carrie M CM; Tai, Guoying G; Rettie, Allan E AE
Publication Date: 2009-06

Variant appearance in text: CYP2C9: F476L
PubMed Link: 19258521
Variant Present in the following documents:
  • Main text
View BVdb publication page



Functional analysis of phenylalanine residues in the active site of cytochrome P450 2C9.

Biochemistry
Mosher, Carrie M CM; Hummel, Matthew A MA; Tracy, Timothy S TS; Rettie, Allan E AE
Publication Date: 2008-11-11

Variant appearance in text: CYP2C9: F476L
PubMed Link: 18922023
Variant Present in the following documents:
  • Main text
View BVdb publication page